日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

泊马度胺在复发或难治性多发性骨髓瘤合并不同程度肾功能损害患者中的群体药代动力学研究

Li, Yan; Wang, Xiaomin; O'Mara, Edward; Dimopoulos, Meletios A; Sonneveld, Pieter; Weisel, Katja C; Matous, Jeffrey; Siegel, David S; Shah, Jatin J; Kueenburg, Elisabeth; Sternas, Lars; Cavanaugh, Chloe; Zaki, Mohamed; Palmisano, Maria; Zhou, Simon

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

STRATUS (MM-010) 研究评估泊马度胺联合低剂量地塞米松治疗难治性多发性骨髓瘤的安全性和有效性:一项 3b 期研究

Dimopoulos, Meletios A; Palumbo, Antonio; Corradini, Paolo; Cavo, Michele; Delforge, Michel; Di Raimondo, Francesco; Weisel, Katja C; Oriol, Albert; Hansson, Markus; Vacca, Angelo; Blanchard, María Jesús; Goldschmidt, Hartmut; Doyen, Chantal; Kaiser, Martin; Petrini, Mario; Anttila, Pekka; Cafro, Anna Maria; Raymakers, Reinier; San-Miguel, Jesus; de Arriba, Felipe; Knop, Stefan; Röllig, Christoph; Ocio, Enrique M; Morgan, Gareth; Miller, Neil; Simcock, Mathew; Peluso, Teresa; Herring, Jennifer; Sternas, Lars; Zaki, Mohamed H; Moreau, Philippe

Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma

MM-003 研究是一项 III 期研究,旨在比较泊马度胺联合低剂量地塞米松与高剂量地塞米松治疗难治性或复发难治性多发性骨髓瘤的疗效,本研究分析了肾功能损害情况。

Weisel, Katja C; Dimopoulos, Meletios A; Moreau, Philippe; Lacy, Martha Q; Song, Kevin W; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Banos, Anne; Oriol, Albert; Alegre, Adrian; Chen, Christine; Cavo, Michele; Garderet, Laurent; Ivanova, Valentina; Martinez-Lopez, Joaquin; Knop, Stefan; Yu, Xin; Hong, Kevin; Sternas, Lars; Jacques, Christian; Zaki, Mohamed H; San Miguel, Jesus

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

泊马度胺和低剂量地塞米松治疗难治性或复发难治性多发性骨髓瘤患者的细胞遗传学和长期生存率

Dimopoulos, Meletios A; Weisel, Katja C; Song, Kevin W; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Moreau, Philippe; Banos, Anne; Oriol, Albert; Garderet, Laurent; Cavo, Michele; Ivanova, Valentina; Alegre, Adrian; Martinez-Lopez, Joaquin; Chen, Christine; Spencer, Andrew; Knop, Stefan; Bahlis, Nizar J; Renner, Christoph; Yu, Xin; Hong, Kevin; Sternas, Lars; Jacques, Christian; Zaki, Mohamed H; San Miguel, Jesus F

Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

既往治疗和缓解深度对 MM-003 生存期的影响:一项随机 3 期研究,比较泊马度胺联合低剂量地塞米松与高剂量地塞米松治疗复发/难治性多发性骨髓瘤的疗效

San Miguel, Jesus F; Weisel, Katja C; Song, Kevin W; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Moreau, Philippe; Banos, Anne; Oriol, Albert; Garderet, Laurent; Cavo, Michele; Ivanova, Valentina; Alegre, Adrian; Martinez-Lopez, Joaquin; Chen, Christine; Renner, Christoph; Bahlis, Nizar Jacques; Yu, Xin; Teasdale, Terri; Sternas, Lars; Jacques, Christian; Zaki, Mohamed H; Dimopoulos, Meletios A

Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

MM-003试验中泊马度胺联合低剂量地塞米松与高剂量地塞米松治疗复发和/或难治性多发性骨髓瘤患者的健康相关生活质量

Song, Kevin W; Dimopoulos, Meletios A; Weisel, Katja C; Moreau, Philippe; Palumbo, Antonio; Belch, Andrew; Schey, Stephen; Sonneveld, Pieter; Sternas, Lars; Yu, Xin; Amatya, Ramesh; Monzini, Mara S; Zaki, Mohamed; Jacques, Christian; San Miguel, Jesus

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

一项针对晚期实体瘤患者的皮下注射阿柏西普(VEGF陷阱)新制剂的I期研究

Wang-Gillam, Andrea; Tew, William P; Rothenberg, Mace L; Dupont, Jakob; Cooper, Wendy; Sternas, Lars; Buzenet, Giliane; Sosman, Jeffrey A; Spriggs, David R; Lockhart, Albert Craig

Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors

一项针对晚期实体瘤患者的静脉注射血管内皮生长因子陷阱药物阿柏西普的I期研究

Lockhart, A Craig; Rothenberg, Mace L; Dupont, Jakob; Cooper, Wendy; Chevalier, Paul; Sternas, Lars; Buzenet, Giliane; Koehler, Elizabeth; Sosman, Jeffrey A; Schwartz, Lawrence H; Gultekin, David H; Koutcher, Jason A; Donnelly, Edwin F; Andal, Ric; Dancy, Isabelle; Spriggs, David R; Tew, William P